Evercore Inc.
EVREvercore Inc. (EVR) is a global independent investment banking advisory firm that provides strategic, financial, and merger and acquisition advice to corporations, financial sponsors, and institutional clients. Founded in 1995, the company is known for its expertise in mergers and acquisitions, restructuring, and capital raising, offering comprehensive advisory services without affiliated underwriting businesses. Its reputation is built on independent advice, deep industry expertise, and a client-focused approach.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2025 | $0.84 | 2025-11-28 | 2025-11-28 |
| September 12, 2025 | $0.84 | 2025-08-29 | 2025-08-29 |
| June 13, 2025 | $0.84 | 2025-05-30 | 2025-05-30 |
| March 14, 2025 | $0.80 | 2025-02-28 | 2025-02-28 |
| December 13, 2024 | $0.80 | 2024-11-29 | 2024-11-29 |
Dividends Summary
- Consistent Payer: Evercore Inc. has rewarded shareholders with 76 dividend payments over the past 18 years.
- Total Returned Value: Investors who held EVR shares during this period received a total of $30.83 per share in dividend income.
- Latest Payout: The most recent dividend of $0.84/share was paid 42 days ago, on December 12, 2025.
- Yield & Schedule: EVR currently pays dividends quarterly with an annual yield of 0.89%.
- Dividend Growth: Since 2007, the dividend payout has grown by 1100.0%, from $0.07 to $0.84.
- Dividend Reliability: EVR has maintained or increased its dividend for 76 consecutive payments.
Company News
ProQR Therapeutics will participate in the 8th Annual Evercore Healthcare Conference, presenting its Axiomer™ RNA editing technology platform that enables targeted single nucleotide changes in RNA to potentially develop new disease treatments.
Madrigal Pharmaceuticals will participate in three upcoming healthcare investor conferences in November and December 2025, presenting live webcasts about their MASH treatment Rezdiffra.
Wall Street analysts predict the S&P 500 could experience significant volatility in 2026, with potential scenarios ranging from a 30% surge to a 30% decline, driven by factors like AI adoption, economic conditions, and potential interest rate changes.
Standard Lithium announced a public offering of 29,885,057 common shares at $4.35 per share, raising $130 million to fund capital expenditures for its lithium projects in Arkansas and Texas.
Sprouts Farmers Market stock has fallen 40% since June, but analysts suggest it may be oversold and poised for a potential rebound ahead of upcoming earnings, citing strong historical performance and technical indicators.
